## Abstract ## Background. Our aim was to gain insight into the incidence rates for, distribution of, and risk factors of postoperative cardiovascular and respiratory complications in major head and neck surgery. ## Methods. We performed a retrospective review of 469 patients who had undergone p
Postoperative myocardial injury after major head and neck cancer surgery
β Scribed by Peter Nagele; Lesley K. Rao; Mrudula Penta; Dorina Kallogjeri; Edward L. Spitznagel; Laura F. Cavallone; Brian Nussenbaum; Jay F. Piccirillo
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 173 KB
- Volume
- 33
- Category
- Article
- ISSN
- 1043-3074
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Background.
Patients with head and neck cancer often have multiple risk factors for coronary artery disease. Yet, little is known about the incidence of postoperative myocardial injury after major head and neck cancer surgery and its clinical relevance. The aim of this study was to determine the risk of postoperative myocardial injury in patients undergoing major head and neck cancer surgery.
Methods.
This was a retrospective cohort study of all patients who underwent major head and neck cancer surgery (n = 378) at a single major academic center from April 2003 to July 2008. Peak postoperative troponin I (TnI) concentration was the primary outcome.
Results.
Of 378 patients who underwent major head and neck cancer surgery, 57 patients (15%) had development of an elevated TnI; 90% of these occurred within the first 24 hours after surgery. Preexisting renal insufficiency (unadjusted OR [OR]: 4.60; 95% CI 1.53β13.82), coronary artery disease (OR: 2.33; 95% CI 1.21β4.50), peripheral vascular disease (OR: 2.83; 95% CI 1.31β6.14), hypertension (OR: 2.22; 95% CI 1.20β4.12), and previous combined chemotherapy and radiation (OR: 2.68; 95% CI 1.04β6.91) were associated with elevated postoperative TnI levels. Patients with elevated TnI levels had a significantly longer length of stay in the hospital (8.5 vs 10.1 days; p = .014) and ICU (3 vs 4.5 days; p = .001) and an 8βfold increased risk of death at 60 days after surgery (adjusted OR: 8.01, 95% CI 2.03β31.56). At 1 year, patients with an abnormal postoperative TnI level were twice as likely to die (OR 1.93; 95% CI 1.02β3.63).
Conclusions.
Patients who undergo major head and neck cancer surgery are at significant risk for postoperative myocardial injury, which is a strong predictor of 60βday mortality after surgery. Monitoring of myocardial injury during the first postoperative days, as well as optimizing preventive cardiac care, may be helpful to reduce postoperative mortality rates. Head Neck, 2011
π SIMILAR VOLUMES
## Abstract ## Background. To compare the rate of postoperative complications of patients with advanced head and neck cancer treated with the chemoradiation protocol βRADPLATβ with that of a similar cohort of patients treated with primary surgery. ## Methods. We retrospectively analyzed 50 patie
## Abstract ## Background. Quality of life has become a major issue in determining the outcome of treatment in head and neck surgery with curative intent. The aim of our study was to determine which factors in the postoperative care, especially shoulder and neck morbidity, are related to quality o
## Abstract ## Background Surgical resection of oral cancer can be associated with significant postoperative cardiovascular and respiratory complications that require more sensitive predictors. ## Methods All patients with oral squamous cell carcinoma treated from July 2005 to April 2008 were re
## Abstract ## Background. Because of the low incidence of late thrombosis in free flaps used for head and neck reconstruction, the risk factors, prognosis, and the optimal method of treatment are unclear. ## Methods. The timing of thrombosis, types of flaps, occluded vessels, causative factors,
## Abstract ## Background. The purpose of this study was to compare the patterns of failure focusing on the distribution of localβregional recurrence among patients treated postoperatively with conventional radiotherapy (RT) and intensityβmodulated radiotherapy (IMRT) for head and neck cancer. ##